AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Impride M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Axis Life Science Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Impride M 1mg/500mg Tablet SR

Diabetace M, a 1mg/500mg extended-release tablet, is an antidiabetic medication combining two active agents for adult type 2 diabetes management. It regulates blood glucose levels. Diabetace M should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencement. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended by your doctor.

Uses of Impride M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Impride M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Impride M 1mg/500mg Extended-Release Tablet with food.

Common Side effects of Impride M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Impride M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Impride M 1mg/500mg Extended-Release Tablet should be taken with a meal.

How Impride M 1mg/500mg Tablet SR works:

Impride M SR tablets (1mg/500mg) combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Impride M 1mg/500mg SR tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Impride M 1mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Extended-release Impride M (1mg/500mg) tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Impride M 1mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Impride M 1mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Impride M 1mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiate treatment with a reduced Impride M 1mg/500mg SR tablet dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Impride M 1mg/500mg Tablet SR :

Should you forget to take your Impride M 1mg/500mg SR Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Impride M 1mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Impride M 1mg/500mg Tablet SR

Retain this medication within its original, sealed container. Follow the storage directions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Taking Impride M 1mg/500mg Tablet SR may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but dangerous side effect is particularly risky for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms can include muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should any of these symptoms appear, discontinue Impride M 1mg/500mg Tablet SR use and seek immediate medical attention.
Impride M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual therapy enhances glycemic control when combined with a suitable diet and exercise regimen. Glimepiride's mechanism involves stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves insulin responsiveness. This formulation is unsuitable for individuals with type 1 diabetes.
Taking Impride M 1mg/500mg Tablet SR may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headaches. Rare but potentially serious side effects such as lactic acidosis may also occur. Prolonged use can result in vitamin B12 deficiency.
Prolonged Impride M 1mg/500mg SR tablet use can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at minimum annually, has been proposed by some investigators.
Indeed, Impride M 1mg/500mg SR tablets can lead to hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming alcohol concurrently with Impride M 1mg/500mg SR tablets is inadvisable due to the risk of reduced blood glucose, potentially causing hypoglycemia. Furthermore, this combination elevates the likelihood of lactic acidosis.
Impride M 1mg/500mg Table...
45
MRP 55
18% off